C4 Therapeutics Eulerpool Haberleri

C4 Therapeutics Eulerpool News

C4 Therapeutics Hisse Haberleri

C4 Therapeutics, dünya çapında birçok gazeteci ve yatırımcı tarafından takip edilmektedir. En güncel C4 Therapeutics haberlerini burada bir araya getiriyoruz.

• 16 Eylül ·

  TipRanks
  Stifel Nicolaus Keeps Their Buy Rating on C4 Therapeutics (CCCC)
• 16 Eylül ·

  TipRanks
  Cautious Hold Rating on C4 Therapeutics Amid Modest Efficacy and Pending Data
• 15 Eylül ·

  TipRanks
  Hold Rating on C4 Therapeutics Amid Early-Stage Drug Development and Market Caution
• 13 Eylül ·

  Yahoo
  C4 Therapeutics Presents Monotherapy Data Demonstrating Proof of Mechanism and Early Evidence of Proof of Concept From Ongoing CFT1946 Phase 1 Trial in BRAF V600 Mutant Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
• 13 Eylül ·

  Thefly.com
  C4 Therapeutics announces next steps for CFT1946
• 10 Eylül ·

  Yahoo
  C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
• 10 Eylül ·

  Stock Options Channel
  Interesting CCCC Call Options For September 20th
• 9 Eylül ·

  Yahoo
  C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
• 4 Eylül ·

  TipRanks
  C4 Therapeutics (CCCC) Gets a Buy from Stifel Nicolaus
• 3 Eylül ·

  Yahoo
  C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors